Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
54.57
-2.07 (-3.65%)
At close: Jul 8, 2026, 4:00 PM EDT
53.97
-0.59 (-1.09%)
After-hours: Jul 8, 2026, 7:16 PM EDT
Structure Therapeutics Market Cap
Structure Therapeutics has a market cap or net worth of $3.9 billion as of July 8, 2026. Its market cap has increased by 206.81% in one year.
Market Cap
3.90B
Enterprise Value
2.45B
1-Year Change
206.81%
Ranking
Category
Stock Price
$54.57
Market Cap Chart
Since the IPO on February 3, 2023, Structure Therapeutics's market cap has increased from $548.82M to $3.90B, an increase of 610.84%. That is a compound annual growth rate of 77.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 8, 2026 | 3.90B | -18.87% |
| Dec 31, 2025 | 4.81B | 209.65% |
| Dec 31, 2024 | 1.55B | -22.02% |
| Dec 29, 2023 | 1.99B | 262.83% |
| Feb 3, 2023 | 548.82M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Edgewise Therapeutics | 4.31B |
| Relay Therapeutics | 4.12B |
| Telix Pharmaceuticals | 4.09B |
| Denali Therapeutics | 4.09B |
| NewAmsterdam Pharma Company | 4.08B |
| Catalyst Pharmaceuticals | 3.86B |
| Dyne Therapeutics | 3.78B |
| Arcus Biosciences | 3.77B |